iLB-294bms22, PH-BL-412 Clone 238

The cell line is not validated yet.


Cell Line

hPSCreg Name
Alternative name(s)
iLB-294bms22, PH-BL-412 Clone 238
Cell line type Human induced pluripotent stem cell (hiPSC)
Last update 1st March 2023
User feedback
No feedback available yet.

Login to share your feedback, experiences or results with the research community.


Generator Life & Brain GmbH (LB)
Derivation country Germany

External Databases

BioSamples SAMEA111531221
CLO CLO_0104418
Cellosaurus CVCL_C6RJ
Wikidata Q117704631

General Information

* Is the cell line readily obtainable for third parties?
Research use: allowed
Clinical use: allowed
Commercial use: not allowed

Donor Information

General Donor Information

Sex male
Age of donor (at collection) 55-59
Ethnicity White European

Phenotype and Disease related information (Donor)

Diseases A disease was diagnosed.
Alzheimer disease
TREM2R47H/WT CD33 full length variant /full length variant
The donor is a carrier of a disease-associated mutation and not affected.
Cognitively normal on the day of sample donation
  • Late-onset form of familial Alzheimer disease
  • Alzheimer disease
Genetic variants
TREM2 (target)

Karyotyping (Donor)

Has the donor karyotype been analysed?

External Databases (Donor)

BioSamples SAMEA111531226


Has informed consent been obtained from the donor of the embryo/tissue from which the pluripotent stem cells have been derived? Yes
Was the consent voluntarily given? Yes
Has the donor been informed that participation will not directly influence their personal treatment? Yes
Can you provide us with a copy of the Donor Information Sheet provided to the donor? Yes
Do you (Depositor/Provider) hold the original Donor Consent Form? No
If you do not hold the Donor Consent Form, do you know who does? Yes
Contact information / weblink
Please indicate whether the data associated with the donated material has been pseudonymised or anonymised. pseudonymised
Does consent explicitly allow the derivation of pluripotent stem cells? Yes
Does consent expressly prevent the derivation of pluripotent stem cells? No
Does consent pertain to a specific research project? No
Does consent permit unforeseen future research, without further consent? Yes
Does consent expressly prevent development of commercial products? No
Does consent expressly prevent financial gain from any use of the donated embryo/tissue, including any product made from it? No
Does consent prevent the DONATED BIOSAMPLE from being made available to researchers anywhere in the world? No
Does consent prevent CELLS DERIVED FROM THE DONATED BIOSAMPLE from being made available to researchers anywhere in the world? No
How may genetic information associated with the cell line be accessed? Controlled Access
Will the donor expect to receive financial benefit, beyond reasonable expenses, in return for donating the biosample? No
Does the consent permit the donor, upon withdrawal of consent, to stop the use of the derived cell line(s) that have already been created from donated samples? No
Does the consent permit the donor, upon withdrawal of consent, to stop delivery or use of information and data about the donor? Yes
Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the Research Protocol including the consent provisions? Yes
Name of accrediting authority involved? Health Research Authority
Approval number 224771
Do you have obligations to third parties in regard to the use of the cell line? Yes
Please describe: EMDA and L&B
Are you aware of any further constraints on the use of the donated embryo/tissue or derived cells? No
For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used?

hIPSC Derivation


Source cell type
erythroid progenitor cell
Committed, erythroid stem cells derived from myeloid stem cells. The progenitor cells develop in two phases: erythroid burst-forming units (bfu-e) followed by erythroid colony-forming units (cfu-e). Bfu-e differentiate into cfu-e on stimulation by erythropoietin, and then further differentiate into erythroblasts when stimulated by other factors.
Source cell origin
A liquid tissue; its major function is to transport oxygen throughout the body. It also supplies the tissues with nutrients, removes waste products, and contains various components of the immune system defending the body against infection. Several hormones also travel in the blood.
  • Reticuloendothelial System, Blood
  • Peripheral Blood
  • peripheral blood
  • blood
  • Blood
  • Whole Blood
show more synonyms
Age of donor (at collection) 55-59
Collected in 2018

Reprogramming method

Vector type Non-integrating
Vector Sendai virus
Is reprogramming vector detectable?
Methods used
Files and images showing reprogramming vector expressed or silenced

Vector free reprogramming


Derived under xeno-free conditions
Derived under GMP?
Available as clinical grade?

Culture Conditions

Surface coating Vitronectin
Feeder cells
Passage method Enzymatically
O2 Concentration 20 %
CO2 Concentration 6 %
Medium Other medium:
Base medium: StemMACS™ iPS-Brew XF, Basal Medium
Main protein source: StemMACS™ iPS Brew XF, 50x Supplement
Serum concentration: %
Has Rock inhibitor (Y27632) been used at passage previously with this cell line?
Has Rock inhibitor (Y27632) been used at cryo previously with this cell line?
Has Rock inhibitor (Y27632) been used at thaw previously with this cell line?


Analysis of Undifferentiated Cells
Marker Expressed Immunostaining RT-PCR FACS Enzymatic Assay Expression Profiles
TRA 1-60
Morphology pictures


Karyotyping (Cell Line)

Has the cell line karyotype been analysed?
46XY, One CNV > 1 MB were observed
Karyotyping method: Molecular karyotyping by SNP array

Other Genotyping (Cell Line)